Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 6 of 20
Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS Pilot)
NCT05938413
MyPEEPS Mobile for Young Transgender Men
NCT05424718
Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients
NCT05812274
Motivation Skills Training for Schizophrenia
NCT05746455
Parental Feelings About Their Child Needing a Central Line
NCT05842356
Nationwide Study of Firearm Violence Prevention Tactics and Policies in K-12 Schools
NCT05552716
Effect of Alpelisib in Healthy Volunteers
NCT05733455
BREATHE-Peds Pilot- II III Trial and Post Trial
NCT05832437
PROtecting Maternal Brains From Injury and Stroke
NCT05726279
Safety and Effectiveness of a Virtual Pediatric Cardiac Rehabilitation Program or Telerehabilitation in Children With Heart Disease
NCT06819059
FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments
NCT05810025
Effectiveness of an Evidence-based Stepped Care System for Alcohol and Other Drug Use Problems Among Congolese Refugees in Zambia
NCT05471921
COVID-19 Self-testing Study
NCT05701878
Exercise Strategies to Motivate and Relieve Stress
NCT05776264
Motor Learning for Upper Limb Hemiparesis After Stroke
NCT05765474
Sleep in SNOO Smart Sleeper Bassinet in Preterm Infants
NCT05711927
Prophylactic Methylergonovine for Twin Cesarean
NCT05772156
Development and Pilot Testing of the Sense2Quit App
NCT05609032
Indoor Air Quality for Black Adults With Uncontrolled Asthma
NCT05685381
Using Teleneuropsychology to Optimize Cognition in Healthy Aging: the Web-based Breakfast Game
NCT05506852
Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD
NCT03901534
Mechanisms and Treatment of Exercise Intolerance and Persistent Fatigue in Spinal Muscular Atrophy
NCT05518773
Zero Suicide Implementation in Outpatient Mental Health Clinics
NCT05587530
Web Based Patient Tutorial on Prolonged Grief
NCT05575817
An Extension Protocol for Patients Who Previously Completed the TMS Pilot Study
NCT05526833
Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations
NCT05319080
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
NCT05635045
Aerobic Exercise in Patients With Stroke
NCT05429255
Utilization of MAsS in Patients Undergoing LT for HCC
NCT05184283
Bile Acids in Acute Insulin Resistance
NCT05571670
Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)
NCT05439928
Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility
NCT04949711
BREATHE-Peds Pilot - I Focus Group Interviews
NCT05137223
The SleepWell Study - Chronotherapeutic Intervention to Improve Sleep Following ACS
NCT05299723
Digital Cognitive-Behavioral Therapy for Insomnia in Spanish Speaking Latinas/os (Dormir Mejor Study)
NCT05353296
Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
NCT04807777
High Calorie High Protein Nutrition Supplementation in Advanced Heart Failure
NCT05219708
Mental Health Support for Transgender and Gender-expansive Individuals
NCT06229132
SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
NCT05233163
Telehealth-enhanced Hybrid Cardiac Rehabilitation Among Acute Coronary Syndrome Survivors
NCT05328375
Impact of Cyanoacrylate Glue on PICC Line Dressing Care
NCT05246709
SMS HPV Vaccine Reminders
NCT05151367
Study of Copanlisib and Ketogenic Diet
NCT04750941
Making PrEP Smart: An HIV Testing and PrEP Electronic Support Tool ("SmartPrEP" App) for Women on PrEP
NCT05111119
Supporting Smoke-Free Policy Compliance in Public Housing
NCT05016505
Training in Ataxia - Individuals With Degenerative Cerebellar Diseases
NCT05002218
Health e-Baby: Trial to Reduce Obesity Risk Factors During the First 1,000 Days
NCT05225649
Twitter Based Social Support for Hispanic and Black Dementia Caregivers
NCT03865498
Neural Correlates of Compulsivity
NCT05195476
Family-Authored ICU Diaries to Reduce Fear in Patients Experiencing a Cardiac Arrest (FAID Fear)
NCT05144477
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Columbia University pipeline card: 958 registered trials from official public datasets.Report a data error.